1. Identification of SMC2 and SMC4 as prognostic markers in breast cancer through bioinformatics analysis.
- Author
-
Pei L, Li Y, Gu H, Wang S, Wu W, Fan S, Shi X, and Si X
- Subjects
- Humans, Female, Prognosis, Animals, Mice, DNA Methylation, Promoter Regions, Genetic, Chromosomal Proteins, Non-Histone genetics, Chromosomal Proteins, Non-Histone metabolism, Mice, Nude, Cell Movement, Adenosine Triphosphatases, Breast Neoplasms genetics, Breast Neoplasms pathology, Breast Neoplasms metabolism, Computational Biology, Biomarkers, Tumor genetics, Biomarkers, Tumor metabolism, Cell Cycle Proteins genetics, Cell Cycle Proteins metabolism
- Abstract
Background: Breast cancer (BRCA) is one of the most common malignant tumors. The structural maintenance of chromosome (SMC) gene family has been shown to play an important role in human cancers. However, the role of SMC families in BRCA is unclear. This study aimed to explore the role and potential clinical value of whole SMCs in BRCA., Methods: TIMER and UALCAN database were used to analysis the expression level. Genetic variations were analyzed by cBioPortal. Promoter methylation and protein level were analyzed by UCLCAN. GO and KEGG were analyzed by Metascape database. Prognostic value of SMCs was analyzed by Kaplan-Meier and multivariate cox regression analyses. Immune infiltration analysis was conducted by CIBERSORT. Immunotherapy outcome prediction was conducted by Cancer Immunome Atlas. Targeted drug therapy outcome prediction was taken by GDSC and R language. The cell viability was tested by CCK8 and migration was tested by wound healing assay. Xenograft model was used to investigate the in vivo role of SMC2., Results: Expression levels of SMC1A, SMC2, SMC4, SMC5 and SMC6 mRNA were increased in BRCA tissues, and negatively correlated with promoter methylation. Overexpression of SMC2 and SMC4 was negatively correlated with survival. Function of SMCs family regulatory genes was mainly related to ATPase activity. Expression of most SMCs was negatively correlated with immunotherapy and drug therapy outcomes. Interfere SMC2 and SMC4 decreased IC
50 values of 5-fluorouracil and oxaliplatin and inhibited the migration of MCF7 cells. Tumor growth and weights were significantly decreased in si-SMC2 groups., Conclusions: Combined bioinformatics and clinical specimen analysis verified SMC2 and SMC4 as independent prognostic factors in BRCA, suggesting their significance for the diagnosis and treatment of BRCA., Competing Interests: Declarations Conflict of interests The authors declare that they have no competing interests. Consent for publication Not applicable., (© 2024. The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO).)- Published
- 2024
- Full Text
- View/download PDF